Iran – MSF “deeply surprised” as Iranian authorities put a stop to the organisation’s COVID-19 response programme
3-25 | Médecins Sans Frontières / Doctors Without Borders (MSF) is ready to deploy its emergency team and inflatable 50-bed facility elsewhere in Iran or to other countries where they are urgently needed. MSF expresses its incomprehension following today’s declarations by officials of the Iranian Ministry of Health stating that the approval for MSF’s intervention to manage severe COVID-19 cases in Isfahan has been rescinded.
3-24 | As the world grapples with the coronavirus COVID-19 global pandemic, Médecins Sans Frontières (MSF) is concerned for vulnerable groups worldwide. People with tuberculosis (TB) are among the groups that may be particularly affected. Special attention will be needed to safeguard the continuity of prevention, diagnosis, treatment and care for people with TB worldwide.
3-24 | MSF started activities in response to COVID-19 in France, focusing on vulnerable people living in the streets, such as migrants. On March 24th, 700 people were evacuated from a vacant lot in Aubervilliers near Paris, where they were living in precarious conditions. They were dispatched on various emergency shelters located in Paris and Ile de France. MSF teams are deployed in some of these shelters to evaluate their health and identify potential COVID-19 cases. The Paris Regional Health Authority is struggling and has asked MSF for help.
3-23 | Médecins Sans Frontières/Doctors Without Borders (MSF) has sent a 50-bed inflatable treatment unit and an emergency team of nine people to Isfahan, the second worst affected province in Iran, to increase hospital capacity for treating the critically ill. MSF is in the process of setting up a treatment unit in Isfahan, Iran to treat patients critically ill with COVID-19. The 50-bed inflatable treatment unit has been shipped by air from MSF’s logistics hub in Bordeaux, France and is to be set up in the compound of Amin Hospital in
3-22 | The COVID-19 pandemic has already spread to more than 100 countries around the world. These include countries whose health systems are fragile and where MSF teams have a long-standing presence, as well as regions such as Europe, where the capacities are more robust but where the epidemic is particularly virulent. Travel restrictions generated by the outbreak also directly affect MSF's work around the world.What questions does MSF face in this context? Clair Mills, MSF’s medical director, explains the challenges.